Concepedia

Author

Leticia Colyn

Universidad de NavarraORCID

Also Known As

L. Colyn, Leticia Colyn

28

Publications

731

Citations

12

H-Index

24

Concepts

All Affiliations

Universidad de NavarraNavarre Institute of Health ResearchUniversidad de SalamancaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y DigestivasInstituto de Investigación Biomédica de Salamanca
LC

About

Leticia Colyn is an author at Universidad de Navarra specializing in medicine, rna splicing, and genome integrity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

158

2

Natural Sciences

1

1

69

3

Social Sciences

1

1

89

4

Cell Biology

1

1

69

5

Molecular Biology

1

1

69

Leticia Colyn

×

10

Publications

496

Citations

10

H-Index

YearCitations

Chronic social defeat stress induces sustained synaptic structural changes in the prefrontal cortex and amygdala

Leticia Colyn, E. Vénzala, Sònia Marco,

Behavioural Brain Research

2019

89

Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis

Marina Bárcena‐Varela, Hannah L. Paish, Laura Álvarez,

Gut

2020

85

Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins

Maddalen Jiménez, Raquel Urtasun, María Elizalde,

Nucleic Acids Research

2019

69

The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis

Eva Santamaría, Carlos M. Rodríguez‐Ortigosa, Iker Uriarte,

Hepatology

2018

64

Dual Targeting of G9a and DNA Methyltransferase‐1 for the Treatment of Experimental Cholangiocarcinoma

Leticia Colyn, Marina Bárcena‐Varela, Gloria Álvarez‐Sola,

Hepatology

2020

60

Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach

Jesús Urmán, José M. Herranz, Iker Uriarte,

Cancers

2020

58

New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

Leticia Colyn, Gloria Álvarez‐Sola, María U. Latasa,

Journal of Experimental & Clinical Cancer Research

2022

32

Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis

Alex Clavería-Cabello, Leticia Colyn, Iker Uriarte,

Cancers

2020

15

Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

Jasmin Elurbide, Leticia Colyn, María U. Latasa,

Gut

2024

14

Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge

Simone Carotti, Maria Zingariello, Maria Francesconi,

Oncogene

2021

10

Page 1